الولايات المتحدة · منصات وبيانات · MarketBeat

Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

نشره MarketBeat · الولايات المتحدة منذ 1 س

Royal Bank Of Canada dropped their price objective on shares of Eyepoint Pharmaceuticals from $5.00 to $1.00 and set a "sector perform" rating for the company in a research note…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

Seeking Alpha

Myriad to sell prenatal health testing business to Labcorp for $210M

MarketWatch

Meet the college students trying to reverse an obscure ban on trading onion futures

The Motley Fool

Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

مشاركة

يستحق القراءة أيضًا

Myriad to sell prenatal health testing business to Labcorp for $210M

Meet the college students trying to reverse an obscure ban on trading onion futures

Dario Amodei's AI Safety Warning Is Colliding With Anthropic's IPO Timeline

Best Tech Stocks Right Now

HSBC CEO warns the AI boom won’t make every data center a good bet

Product DNA and Climate Pacer Launch Solution to Uncover Supply Chain Climate Risks Beyond Tier 1